These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 16780770)

  • 21. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR.
    Tang XQ; Bi H; Feng JQ; Cao JG
    Acta Pharmacol Sin; 2005 Aug; 26(8):1009-16. PubMed ID: 16038636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
    Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
    Zhu L; Lang J; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists.
    Fu J; Chen Z; Cen J; Ruan C
    Chin Med J (Engl); 2000 Mar; 113(3):228-31. PubMed ID: 11775252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
    Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A; Seth K; Kalra N; Shukla Y
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of DNA damage, cell cycle and apoptosis in human K562 and CCRF-CEM leukemia cells: role of BCR/ABL in therapeutic resistance.
    Pytel D; Wysocki T; Majsterek I
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Sep; 144(1):85-92. PubMed ID: 16904383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Azacytidine modulates the response of sensitive and multidrug-resistant K562 leukemic cells to cytostatic drugs.
    Efferth T; Futscher BW; Osieka R
    Blood Cells Mol Dis; 2001; 27(3):637-48. PubMed ID: 11482878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advantage of in vivo chemosensitivity assay to detect vincristine-resistance in a human epidermoid carcinoma xenograft.
    Abe Y; Yamazaki H; Oshika Y; Suto R; Tsugu A; Ota E; Satoh H; Ohnishi Y; Yanagawa T; Ueyama Y; Tamaoki N; Nakamura M
    Anticancer Res; 1996; 16(2):729-34. PubMed ID: 8687121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
    Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
    Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
    Urasaki Y; Ueda T; Yoshida A; Fukushima T; Takeuchi N; Tsuruo T; Nakamura T
    Anticancer Res; 1996; 16(2):709-14. PubMed ID: 8687117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human multi-drug resistant hepatocellular carcinoma induced in nude mice by B-ultrasonographically-directed orthotopic implantation: a new experimental model.
    Ding L; Chen XP; Zhang ZW; Jing K; Zhang WG
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):393-8. PubMed ID: 17690036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine.
    Baran Y; Gunduz U; Ural AU
    Exp Oncol; 2006 Jun; 28(2):163-5. PubMed ID: 16837911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
    Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
    Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver.
    Arora A; Seth K; Shukla Y
    Carcinogenesis; 2004 Jun; 25(6):941-9. PubMed ID: 14729595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression.
    Breier A; Stefanková Z; Barancík M; Tribulová N
    Gen Physiol Biophys; 1994 Aug; 13(4):287-98. PubMed ID: 7890145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synergistic inhibitory effect of STI571 in combination with arsenic trioxide on a multidrug-resistant leukemia cell line expressing bcr-abl].
    Chen L; Wang JM; Xu XP; Gao L; Fei XH; Lou JW; Huang ZX
    Zhonghua Zhong Liu Za Zhi; 2004 Sep; 26(9):535-8. PubMed ID: 15555283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
    Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
    Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.